NO20001492L - Method of preventing abuse of transdermal therapeutic system - Google Patents

Method of preventing abuse of transdermal therapeutic system

Info

Publication number
NO20001492L
NO20001492L NO20001492A NO20001492A NO20001492L NO 20001492 L NO20001492 L NO 20001492L NO 20001492 A NO20001492 A NO 20001492A NO 20001492 A NO20001492 A NO 20001492A NO 20001492 L NO20001492 L NO 20001492L
Authority
NO
Norway
Prior art keywords
therapeutic system
transdermal therapeutic
preventing abuse
abuse
preventing
Prior art date
Application number
NO20001492A
Other languages
Norwegian (no)
Other versions
NO20001492D0 (en
NO319163B1 (en
Inventor
Frank Becher
Ann-Katrin Klink
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of NO20001492D0 publication Critical patent/NO20001492D0/en
Publication of NO20001492L publication Critical patent/NO20001492L/en
Publication of NO319163B1 publication Critical patent/NO319163B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Anesthesiology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electrotherapy Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Radiation-Therapy Devices (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Electrolytic Production Of Non-Metals, Compounds, Apparatuses Therefor (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

According to the invention, denaturing agents are added to a transdermal therapeutic system to prevent misuse in the form of unauthorised oral application.
NO20001492A 1997-10-01 2000-03-22 Transdermal therapeutic system that prevents abuse NO319163B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19743484A DE19743484C1 (en) 1997-10-01 1997-10-01 Transdermal patches containing substance with unpleasant taste
PCT/EP1998/005955 WO1999016428A1 (en) 1997-10-01 1998-09-18 Method for preventing the misuse of a transdermal therapeutic system

Publications (3)

Publication Number Publication Date
NO20001492D0 NO20001492D0 (en) 2000-03-22
NO20001492L true NO20001492L (en) 2000-03-22
NO319163B1 NO319163B1 (en) 2005-06-27

Family

ID=7844345

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20001492A NO319163B1 (en) 1997-10-01 2000-03-22 Transdermal therapeutic system that prevents abuse
NO20001691A NO20001691L (en) 1997-10-01 2000-03-31 Childproof packaging for pressure sensitive products that also have a relatively large surface area, such as transdermal therapeutic systems (TTS)

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20001691A NO20001691L (en) 1997-10-01 2000-03-31 Childproof packaging for pressure sensitive products that also have a relatively large surface area, such as transdermal therapeutic systems (TTS)

Country Status (23)

Country Link
EP (1) EP1019032B1 (en)
JP (2) JP4755338B2 (en)
KR (1) KR100552102B1 (en)
AT (1) ATE228356T1 (en)
AU (1) AU759609B2 (en)
CA (1) CA2305432C (en)
DE (2) DE19743484C1 (en)
DK (1) DK1019032T3 (en)
ES (1) ES2188021T3 (en)
HK (1) HK1029919A1 (en)
HU (1) HU226644B1 (en)
ID (1) ID24333A (en)
IL (1) IL134479A (en)
MY (1) MY116425A (en)
NO (2) NO319163B1 (en)
NZ (1) NZ503643A (en)
PL (1) PL193066B1 (en)
PT (1) PT1019032E (en)
SK (1) SK3332000A3 (en)
TR (1) TR200000461T2 (en)
TW (1) TW431894B (en)
WO (1) WO1999016428A1 (en)
ZA (1) ZA988904B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19743484C1 (en) * 1997-10-01 1999-01-28 Lohmann Therapie Syst Lts Transdermal patches containing substance with unpleasant taste
GB0026137D0 (en) * 2000-10-25 2000-12-13 Euro Celtique Sa Transdermal dosage form
US7867511B2 (en) * 2004-01-23 2011-01-11 Travanti Pharma Inc. Abuse potential reduction in abusable substance dosage form
DE102004019916A1 (en) * 2004-04-21 2005-11-17 Grünenthal GmbH Anti-abuse drug-containing patch
JP7329857B2 (en) * 2018-10-17 2023-08-21 日榮新化株式会社 Adhesive sheet and its manufacturing method

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8804164D0 (en) * 1988-02-23 1988-03-23 Tucker J M Bandage for administering physiologically active compound
US5236714A (en) * 1988-11-01 1993-08-17 Alza Corporation Abusable substance dosage form having reduced abuse potential
US5149538A (en) * 1991-06-14 1992-09-22 Warner-Lambert Company Misuse-resistive transdermal opioid dosage form
DE4342174C1 (en) * 1993-12-10 1995-05-11 Lohmann Therapie Syst Lts Transdermal therapeutic system and a method for producing a transdermal therapeutic system for the combined transdermal application of physostigmine and scopolamine for the prophylaxis and pretreatment of poisoning by highly toxic organophosphorus neurotoxins, in particular Soman and its use
DE19743484C1 (en) * 1997-10-01 1999-01-28 Lohmann Therapie Syst Lts Transdermal patches containing substance with unpleasant taste

Also Published As

Publication number Publication date
PL339736A1 (en) 2001-01-02
DE19743484C1 (en) 1999-01-28
TR200000461T2 (en) 2000-09-21
IL134479A (en) 2005-07-25
CA2305432A1 (en) 1999-04-08
DK1019032T3 (en) 2003-03-10
HUP0003476A3 (en) 2001-04-28
DE59806468D1 (en) 2003-01-09
ZA988904B (en) 1999-04-12
HU226644B1 (en) 2009-05-28
JP4755338B2 (en) 2011-08-24
ID24333A (en) 2000-07-13
NO20001691D0 (en) 2000-03-31
NZ503643A (en) 2003-05-30
TW431894B (en) 2001-05-01
HUP0003476A2 (en) 2001-02-28
EP1019032B1 (en) 2002-11-27
NO20001691L (en) 2000-03-31
ATE228356T1 (en) 2002-12-15
CA2305432C (en) 2007-04-03
KR100552102B1 (en) 2006-02-13
HK1029919A1 (en) 2001-04-20
JP2009035561A (en) 2009-02-19
IL134479A0 (en) 2001-04-30
AU759609B2 (en) 2003-04-17
EP1019032A1 (en) 2000-07-19
MY116425A (en) 2004-01-31
SK3332000A3 (en) 2000-11-07
ES2188021T3 (en) 2003-06-16
NO20001492D0 (en) 2000-03-22
JP2001517695A (en) 2001-10-09
PL193066B1 (en) 2007-01-31
WO1999016428A1 (en) 1999-04-08
NO319163B1 (en) 2005-06-27
PT1019032E (en) 2003-04-30
AU9626598A (en) 1999-04-23
KR20010030886A (en) 2001-04-16

Similar Documents

Publication Publication Date Title
DE69832055D1 (en) TRANSDERMAL DELIVERY SYSTEM
IT1302020B1 (en) TRANSDERMAL PATCH.
DE69724235D1 (en) Computer system and software protection method
IL149890A0 (en) Tnt-alpha antagonist and lfa-1 antagonist for treating lfa-1 or tnf-alpha mediated
DK1143967T3 (en) Anticonvulsant derivatives suitable for the treatment of Horton's headache
PT966447E (en) SMALL UTILIZATION MOLECULES IN THE TREATMENT OF INFLAMMATORY DISEASES
DK1001761T3 (en) Use of cholinesterase inhibitors to treat attention deficit disorders
MXPA03011825A (en) Active ingredient combination for treating a dependence on addictive substances or narcotics using medicaments.
DE69720972D1 (en) Computer system and software protection method
ITTO950433A0 (en) FOLDABLE SAFETY PROTECTOR FOR SYRINGE NEEDLES IN GENERAL.
ATE241338T1 (en) DRUG DELIVERY SYSTEM, IN PARTICULAR FOR ADMINISTRATION OF ANDROGENS
DK1220852T3 (en) Substituted diazepanes
DE69720971D1 (en) Computer system and software protection method
NO20001492L (en) Method of preventing abuse of transdermal therapeutic system
DE69915690D1 (en) ANTI-CONVULSIVE DERIVATIVES FOR TREATING POST-TRAUMATIC STRESS DISEASES
IT1292319B1 (en) SAFETY ROAD BARRIER.
DE60222552D1 (en) CARBAMATES OF 2-HETEROCYCLIC 1,2-ETHANEDIOLS
DE60039122D1 (en) 6-O-ALKYL-2-NOR-2-SUBSTITUTED KETOLID DERIVATIVES
IT1299990B1 (en) SAFETY PADLOCK WITHOUT CONNECTION ARCH.
ATE339212T1 (en) POTENTIATION OF SN-38 PRODROGEN EFFECTIVENESS
UA32360A (en) Method for treating extensive chronic dermatosis
UA36385A (en) Method for treating generalized periodontitis
NL1001319A1 (en) Asphalt road treatment equipment.
ZA200107591B (en) Transdermal therapy system and method for producing the same.
WO2000067733A3 (en) Medicament for treating human infertility

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees